The international postgraduate ULG Health Outcome Research jointly organized by VSCR and SFU took place from 27-29 May 2019 at the Sigmund Freud University Vienna. There were postgraduate students from 20 different nations.
The speakers came from Austria, Switzerland, Belgium, France and Dubai. The language of instruction was English.
The key note lecture about CURRENT AND FUTURE ADVANCEMENTS IN CANCER THERAPY – HOW TO BALANCE BENEFITS AND COSTS FOR SOCIETY was given by Univ.-Prof. Dr. Heinz Ludwig, Oncologist, Wilheminenspital, Vienna followed by a public panel discussion with national and international stakeholders.
The repetition of this module Evidence-Based Decision Making for Pricing and Reimbursement will take place from 21 to 23 October 2019 in Vienna.
Opening Key Note Lecture and public panel discussion
Key note lecture
Public panel discussion
left to right. Dr. Robin Rumler (Country Manager Pfizer Austria)
Helga Thurnher (patient organization colon cancer)
Boris Azaïs, MA (Director Public Policy Europe Canada- MSD, France)
Mag. Ronald Pichler (Head of Public Affairs and Market Access, Pharmig – Association of the Austrian Pharmaceutical Industry)
DrDr. Wolfgang Wein (General Manager Merck Austria)
Univ.-Prof. Dr. Heinz Ludwig (Oncologist, Wilheminenspital, Vienna)
Dr. Anna Bucsics (Former Department Head, Department of Pharmaceutical Affairs, Federation of Austrian Social Insurance Institutions)